177 related articles for article (PubMed ID: 19937931)
1. Incidence of nephrogenic systemic fibrosis at Chinese PLA General Hospital.
Zou Z; Ma L; Li H
J Magn Reson Imaging; 2009 Dec; 30(6):1309-12. PubMed ID: 19937931
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for NSF: a literature review.
Prince MR; Zhang HL; Roditi GH; Leiner T; Kucharczyk W
J Magn Reson Imaging; 2009 Dec; 30(6):1298-308. PubMed ID: 19937930
[TBL] [Abstract][Full Text] [Related]
3. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.
Wang Y; Alkasab TK; Narin O; Nazarian RM; Kaewlai R; Kay J; Abujudeh HH
Radiology; 2011 Jul; 260(1):105-11. PubMed ID: 21586680
[TBL] [Abstract][Full Text] [Related]
4. Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patients.
Abujudeh HH; Rolls H; Kaewlai R; Agarwal S; Gebreananya ZA; Saini S; Schaefer PW; Kay J
J Magn Reson Imaging; 2009 Dec; 30(6):1335-40. PubMed ID: 19937927
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic systemic fibrosis: clinical spectrum of disease.
Mayr M; Burkhalter F; Bongartz G
J Magn Reson Imaging; 2009 Dec; 30(6):1289-97. PubMed ID: 19937929
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
Weinreb JC; Abu-Alfa AK
J Magn Reson Imaging; 2009 Dec; 30(6):1236-9. PubMed ID: 19938035
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study.
Janus N; Launay-Vacher V; Karie S; Clement O; Ledneva E; Frances C; Choukroun G; Deray G
Eur J Radiol; 2010 Feb; 73(2):357-9. PubMed ID: 19128909
[TBL] [Abstract][Full Text] [Related]
8. Incidence of nephrogenic systemic fibrosis at two large medical centers.
Prince MR; Zhang H; Morris M; MacGregor JL; Grossman ME; Silberzweig J; DeLapaz RL; Lee HJ; Magro CM; Valeri AM
Radiology; 2008 Sep; 248(3):807-16. PubMed ID: 18710976
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
Prince MR; Zhang HL; Prowda JC; Grossman ME; Silvers DN
Radiographics; 2009 Oct; 29(6):1565-74. PubMed ID: 19959508
[TBL] [Abstract][Full Text] [Related]
10. Renovascular imaging in the NSF Era.
Roditi G; Maki JH; Oliveira G; Michaely HJ
J Magn Reson Imaging; 2009 Dec; 30(6):1323-34. PubMed ID: 19937926
[TBL] [Abstract][Full Text] [Related]
11. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
Kribben A; Witzke O; Hillen U; Barkhausen J; Daul AE; Erbel R
J Am Coll Cardiol; 2009 May; 53(18):1621-8. PubMed ID: 19406336
[TBL] [Abstract][Full Text] [Related]
12. Guideline to use gadolinium-based contrast agents at Kyoto University Hospital.
Miki Y; Isoda H; Togashi K
J Magn Reson Imaging; 2009 Dec; 30(6):1364-5. PubMed ID: 19937936
[TBL] [Abstract][Full Text] [Related]
13. Incidence of nephrogenic systemic fibrosis at a large university hospital in Sweden.
Alhadad A; Sterner G; Svensson Å; Alhadad H; Leander P
Scand J Urol Nephrol; 2012 Feb; 46(1):48-53. PubMed ID: 22008005
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
15. Removal of gadolinium by dialysis: review of different strategies and techniques.
Silberzweig JI; Chung M
J Magn Reson Imaging; 2009 Dec; 30(6):1347-9. PubMed ID: 19937933
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis and management of high-risk patients.
Altun E; Semelka RC; Cakit C
Acad Radiol; 2009 Jul; 16(7):897-905. PubMed ID: 19375360
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of NSF: New evidence challenging the prevailing theory.
Newton BB; Jimenez SA
J Magn Reson Imaging; 2009 Dec; 30(6):1277-83. PubMed ID: 19937925
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the incidence of nephrogenic systemic fibrosis in patients with moderate renal insufficiency administered gadobenate dimeglumine for MRI.
Bryant BJ; Im K; Broome DR
Clin Radiol; 2009 Jul; 64(7):706-13. PubMed ID: 19520215
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic systemic fibrosis: history and epidemiology.
Thomsen HS
Radiol Clin North Am; 2009 Sep; 47(5):827-31, vi. PubMed ID: 19744597
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis: center case review.
Lauenstein TC; Salman K; Morreira R; Tata S; Tudorascu D; Baramidze G; Singh-Parker S; Martin DR
J Magn Reson Imaging; 2007 Nov; 26(5):1198-203. PubMed ID: 17969162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
